Offer - Urjas Oil for just ₹ 1 X
Brilinta, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Heart Attack. Secondary and off-label uses of Brilinta have also been mentioned below.
The optimal dosage of Brilinta is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Brilinta can also lead to other problems, which have been listed below. These side effects of Brilinta are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Brilinta has a Moderate effect for pregnant women and Unknown effect on lactating mothers. It is important to know if Brilinta has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Brilinta related warnings section.
Brilinta is contraindicated in people with pre-existing medical conditions like Liver Disease, Bradycardia (Slow Heart Rate), Peptic Ulcer as it can result in adverse effects. Other contraindications of Brilinta have been discussed in the sections ahead.
Besides this, Brilinta may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Brilinta, it is important to know that it is safe while driving, and is habit-forming.
Brilinta is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Brilinta safe for pregnant women?
Brilinta can have harmful effects in pregnant women. If you experience any discomfort after using Brilinta, then discontinue the use and take your doctor's advice.
Is the use of Brilinta safe during breastfeeding?
No research work has been carried out till date on effect of Brilinta on breastfeeding women. So it is not known whether taking Brilinta will cause side effects or not.
What is the effect of Brilinta on the Kidneys?
Brilinta is not harmful for kidneys.
What is the effect of Brilinta on the Liver?
Brilinta may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Brilinta on the Heart?
Side effects of Brilinta rarely affect the heart.
Brilinta should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Brilinta unless your doctor advises you to do so -
Is this Brilinta habit forming or addictive?
No, there is no any evidence that Brilinta is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Brilinta as it does not make you drowsy.
Is it safe?
Yes, but take Brilinta only as per medical advice.
Is it able to treat mental disorders?
Brilinta is unable to treat or cure mental disorders.
Interaction between Food and Brilinta
Due to a lack of research, nothing can be said about the consequences of taking Brilinta together with food.
Interaction between Alcohol and Brilinta
Information about the interaction of Brilinta and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Brilinta® (ticagrelor)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1204-1205